IMMUNOlogical microenvironment in REctal Adenocarcinoma Treatment (IMMUNOREACT 2; NCT04917263): preliminary results on prediction of complete response to neoadjuvant therapy in rectal cancerGaya Spolverato, Marco Scarpa, Imerio Angriman et al.|European Journal of Surgical Oncology|2022Cited by 0
IMMUNOlogical microenvironment in REctal Adenocarcinoma Treatment (IMMUNOREACT 1; NCT04915326): preliminary results on prediction of presence of nodal metastasis in early rectal cancerGaya Spolverato, Marco Scarpa, Salvatore Pucciarelli et al.|European Journal of Surgical Oncology|2022Cited by 0